Moxit Shah, DM Endocrinology , for personalized treatment plans, including the latest GLP-1 medications such as semaglutide and tirzepatide, along with nutrition and lifestyle guidance tailored to your needs
Statistical analyses To describe the characteristics of patients in the cohort study, mean and standard deviation (SD) were presented for continuous data, and number ( n ) and percentage (%) were presented for categorical covariates
GLP-1 agonists are being used in combination with basal insulin (Dungan & DeSantis, 2016), although this is not an FDA-approved indication (see rxlist.com) they should not be used as a substitute for basal insulin, as this has been found to result in a decline in glycemic control)(Dungan & DeSantis, 2016) Clinical trials indicate it can reduce HbA1c by ~0.8% Undergoes renal clearance, with dosage reduction needed if creatinine clearance falls to 1.5
Write the reconstitution date on the vial so you don't lose track
CoverMyMeds and others publish criteria libraries, but errors can occur